Alex Abramson, PhD is an Assistant Professor in the School of Chemical and Biomolecular Engineering at Georgia Tech. His research, which focuses on drug delivery and bioelectronic therapeutics, has been featured in news outlets such as The New York Times, NPR, and Wired. Alex has received several recognitions for scientific innovation, including being named a member of Forbes 30 Under 30. Alex is passionate about translating scientific endeavors from bench to bedside. Large pharmaceutical companies have exclusively licensed a portfolio of his patents to bring into clinical trials, and Alex serves as a scientific advisor overseeing their commercialization.